APA (7th ed.) Citation

Goyal, A., Agrawal, A., Verma, A., & Dubey, N. (2023). The PI3K-AKT pathway: A plausible therapeutic target in Parkinson's disease. Experimental and molecular pathology, 129, 104846. https://doi.org/10.1016/j.yexmp.2022.104846

Chicago Style (17th ed.) Citation

Goyal, Ahsas, Anant Agrawal, Aanchal Verma, and Nandini Dubey. "The PI3K-AKT Pathway: A Plausible Therapeutic Target in Parkinson's Disease." Experimental and Molecular Pathology 129 (2023): 104846. https://doi.org/10.1016/j.yexmp.2022.104846.

MLA (9th ed.) Citation

Goyal, Ahsas, et al. "The PI3K-AKT Pathway: A Plausible Therapeutic Target in Parkinson's Disease." Experimental and Molecular Pathology, vol. 129, 2023, p. 104846, https://doi.org/10.1016/j.yexmp.2022.104846.